Skip to main content
Equibles
MNKD logo

MNKD · Mannkind Corp · Metrics

Track MNKD — free

Use MNKD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MNKD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.19 -0.01 (-0.31%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$1.03B
Shares
321.54M
Volume · Oct 23 3.09M Avg daily vol (3M) 4.43M

MNKD metrics

98 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.19
Market cap
$1.03B

Price action

20 metrics
Price change (1W)
+4.9%
Price change (30D)
-4.5%
Price change (3M)
-22.8%
Price change (6M)
+18.1%
Price change (YTD)
-43.7%
Price change (1Y)
-41.9%
Trailing year
Price change (5Y)
-31.3%
52-week high
$6.21
52-week low
$2.28
Change from 52-week high
-48.6%
Change from 52-week low
+39.9%
Annualized volatility
70.7%
Annualized volatility (3M)
62.4%
Beta
1.1
RSI (14D)
42.7
Price vs SMA 50
-12.7%
Price vs SMA 200
-15.8%
Avg volume (3M)
4.43M
Relative volume
0.7
Average dollar volume
$16.53M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
321.54M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
3.1×
reciprocal yield 31.9%
EV / EBITDA
41.0×
reciprocal yield 2.4%
EV / EBIT
134.2×
reciprocal yield 0.7%
P / sales
2.6×
reciprocal yield 38.4%
P / book
—
FCF yield
-1.8%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-4.3%

Historical valuation

8 metrics
P / E historical average (3Y)
82.2×
reciprocal yield 1.2%
P / E historical average (5Y)
82.2×
reciprocal yield 1.2%
EV / revenue historical average (3Y)
5.2×
reciprocal yield 19.3%
EV / revenue historical average (5Y)
8.5×
reciprocal yield 11.8%
EV / EBIT historical average (3Y)
52.3×
reciprocal yield 1.9%
EV / EBIT historical average (5Y)
52.3×
reciprocal yield 1.9%
EV / EBITDA historical average (3Y)
28.9×
reciprocal yield 3.5%
EV / EBITDA historical average (5Y)
28.9×
reciprocal yield 3.5%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
89.8%
Operating margin
2.3%
Trailing 12 months
Net margin
-11.1%
Gross profit (TTM)
$353.29M
Operating profit (TTM)
$9.19M
Net income (TTM)
−$43.61M
Trailing 12 months
Diluted EPS (TTM)
$-0.13
FCF margin
-4.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$1.27
Gross profit per diluted share (TTM)
$1.14
Operating profit per diluted share (TTM)
$0.03
EBITDA per diluted share (TTM)
$0.10
Net income per diluted share (TTM)
$-0.14
Operating cash flow per diluted share (TTM)
$-0.03
Free cash flow per diluted share (TTM)
$-0.06
Capital expenditures per diluted share (TTM)
$0.03
R&D per diluted share (TTM)
$0.25
Stock compensation per diluted share (TTM)
$0.09
Book value per share
$-0.17

Growth

11 metrics
Revenue growth YoY
+42.9%
Year over year
Net income growth YoY
-2,949.1%
Revenue (TTM)
$393.63M
Trailing 12 months
EPS growth YoY
-80.0%
Shares change YoY
-0.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+51.8%
Revenue CAGR (5Y)
+39.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-6.0%
Debt / equity
—
Current ratio
1.7
EBITDA (TTM)
$30.06M
Free cash flow (TTM)
−$18.14M
Quick ratio
1.4
Interest coverage
0.3
Net debt / EBITDA
6.9
Return on invested capital
—
Trailing 12 months
Net cash
−$207.96M
Latest balance sheet
Cash & equivalents
$52.93M
Total assets
$732.30M
Total debt
$319.08M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$8.05M
Capital expenditures (TTM)
$10.08M
R&D (TTM)
$76.88M
SG&A (TTM)
$199.89M
Stock compensation (TTM)
$27.97M
R&D / revenue
19.5%
Stock compensation / revenue
7.1%

Ownership (13F)

9 metrics
13F filers
261
13F filer change QoQ
+8
Institutional ownership
57.6%
Conviction holders (share of 13F filers)
0.8%
Crowding (high-turnover and private-fund holders)
15.5%
Private-fund adviser ownership
15.2%
Active holders' share change QoQ
+10.6%
Holder tenure
12.9
Price vs estimated holder cost
+11.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
16.8%

Short interest

3 metrics
Short interest
8.1%
Latest settlement · 4.4 days to cover
Days to cover
4.4d
Short-squeeze score
50 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$414,881
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 899460 CUSIP 56400P706 13F (30d) 37 filings 36 filers Visit website Investor relations